Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Australian Genomics Health Alliance, Parkville, VIC 3052, Australia.
Curr Oncol. 2023 Jul 29;30(8):7241-7251. doi: 10.3390/curroncol30080525.
Over the last decade, utilization of clinical genetics services has grown rapidly, putting increasing pressure on the workforce available to deliver genetic healthcare. To highlight the policy challenges facing Canadian health systems, a needs-based workforce requirements model was developed to determine the number of Canadian patients in 2030 for whom an assessment of hereditary cancer risk would be indicated according to current standards and the numbers of genetic counsellors, clinical geneticists and other physicians with expertise in genetics needed to provide care under a diverse set of scenarios. Our model projects that by 2030, a total of 90 specialist physicians and 326 genetic counsellors (1.7-fold and 1.6-fold increases from 2020, respectively) will be required to provide Canadians with indicated hereditary cancer services if current growth trends and care models remain unchanged. However, if the expansion in eligibility for hereditary cancer assessment accelerates, the need for healthcare providers with expertise in genetics would increase dramatically unless alternative care models are widely adopted. Increasing capacity through service delivery innovation, as well as mainstreaming of cancer genetics care, will be critical to Canadian health systems' ability to meet this challenge.
在过去的十年中,临床遗传学服务的利用率迅速增长,这给提供遗传医疗保健的现有劳动力带来了越来越大的压力。为了突出加拿大卫生系统面临的政策挑战,开发了一种基于需求的劳动力需求模型,以确定根据当前标准,2030 年加拿大有多少患者需要进行遗传性癌症风险评估,以及在各种情况下提供护理所需的遗传咨询师、临床遗传学家和其他具有遗传学专业知识的医生的数量。我们的模型预测,如果当前的增长趋势和护理模式保持不变,到 2030 年,总共需要 90 名专科医生和 326 名遗传咨询师(分别比 2020 年增加 1.7 倍和 1.6 倍),为加拿大提供遗传性癌症服务。然而,如果遗传性癌症评估资格的扩大加速,具有遗传学专业知识的医疗保健提供者的需求将大幅增加,除非广泛采用替代护理模式。通过服务交付创新和癌症遗传学护理的主流化来增加能力,对于加拿大卫生系统应对这一挑战至关重要。